Cargando…
Inhibition of p53 Protein Phosphorylation by 9‐Hydroxyellipticine: A Possible Anticancer Mechanism
Abnormality of p53, a tumor suppressor gene, is considered to be a potential cause of malignancy. We found that ellipticine and 9‐hydroxyellipticine (9HE), antitumor alkaloids, caused selective inhibition of p53 protein phospborylation in Lewis lung carcinoma and SW480 (human colon cancer cell line)...
Autores principales: | Ohashi, Motoaki, Sugikawa, Emiko, Nakanishi, Noriyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920929/ https://www.ncbi.nlm.nih.gov/pubmed/7591958 http://dx.doi.org/10.1111/j.1349-7006.1995.tb03091.x |
Ejemplares similares
-
Design, Synthesis and In Vitro Activity of Anticancer Styrylquinolines. The p53 Independent Mechanism of Action
por: Mrozek-Wilczkiewicz, Anna, et al.
Publicado: (2015) -
p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors
por: Sonnemann, J, et al.
Publicado: (2014) -
Anticancer Therapeutic Strategies Targeting p53 Aggregation
por: Ferretti, Giulia D. S., et al.
Publicado: (2022) -
Activation of p53: How phosphorylated Ser15 triggers sequential phosphorylation of p53 at Thr18 by CK1δ
por: Nicolaou, Sonia T., et al.
Publicado: (2022) -
Growth Inhibition by Anchorage‐deficiency Is Associated with Increased Level but Reduced Phosphorylation of Mutant p53
por: Takahashi, Kazuhide, et al.
Publicado: (1992)